logo-loader
viewDS Smith plc

DS Smith shares rise after strong full-year results

financial_data350_4fec1f82d2f9f.jpg

Shares in DS Smith (LON:SMDS) rose in early trade after the packaging and office product wholesaler reported strong results for the full-year to the end of April 2012.

Revenue rose 12 percent year-on-year to £1.97 billion, and was up 8 percent on a like-for-like basis, while pretax profit soared to £110.2 million from £76.7 million a year earlier.

By 10 am, the stock was trading up 2.7 percent at 140 pence.

The full year benefits from its acquisition in 2010 of French peer Otor acquisition are ahead of original plans, and during the current year it plans to fully integrate Swedish firm SCA Packaging which it recently acquired.

Chief executive Miles Roberts said: "The economic conditions across Europe remain challenging. DS Smith is positioned to perform well in this environment, due to our resilient customer base, the opportunity for substantial cost and cash synergies as previously announced, and our track record of delivering sustainable returns in challenging market conditions.

“Accordingly, the board views the prospects for the enlarged group in the coming year with confidence and expects to make continued progress," he added.

Quick facts: DS Smith plc

Price: 376.7849 GBX

LSE:SMDS
Market: LSE
Market Cap: £5.17 billion
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Full interview: CytoDyn reveals its drug inhibits colon carcinoma metastases...

CytoDyn Inc (OTCMKTS:CYDY) CEO Nader Pourhassan tells Proactive its flagship drug leronlimab inhibited a human colon carcinoma cell line metastases to liver and lung in a well-accepted mouse model. Pourhassan says the company plans to file an IND for expanded access for a Phase 2 basket...

15 hours, 49 minutes ago

RNS

Holding(s) in Company

2 weeks ago

Total Voting Rights

2 weeks, 5 days ago

Pre-close statement

2 weeks, 6 days ago

Holding(s) in Company

4 weeks, 1 day ago

Holding(s) in Company

on 10/08/2019

Holding(s) in Company

on 10/07/2019

2 min read